These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27068938)

  • 1. Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?
    Boardman D; Maher J; Lechler R; Smyth L; Lombardi G
    Biochem Soc Trans; 2016 Apr; 44(2):342-8. PubMed ID: 27068938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy With Regulatory T Cells: A Beneficial Alliance.
    Biswas M; Kumar SRP; Terhorst C; Herzog RW
    Front Immunol; 2018; 9():554. PubMed ID: 29616042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cell therapy: Current and future design perspectives.
    Rana J; Biswas M
    Cell Immunol; 2020 Oct; 356():104193. PubMed ID: 32823038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology.
    Mohseni YR; Tung SL; Dudreuilh C; Lechler RI; Fruhwirth GO; Lombardi G
    Front Immunol; 2020; 11():1608. PubMed ID: 32793236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.
    MacDonald KG; Hoeppli RE; Huang Q; Gillies J; Luciani DS; Orban PC; Broady R; Levings MK
    J Clin Invest; 2016 Apr; 126(4):1413-24. PubMed ID: 26999600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
    J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.
    Hoeppli RE; MacDonald KG; Levings MK; Cook L
    HLA; 2016 Jul; 88(1-2):3-13. PubMed ID: 27256587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor specificity of CD8(+) Tregs in allotransplantation.
    Picarda E; Anegon I; Guillonneau C
    Immunotherapy; 2011 Apr; 3(4 Suppl):35-7. PubMed ID: 21524168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of human islet-specific regulatory T cells by TCR gene transfer.
    Hull CM; Nickolay LE; Estorninho M; Richardson MW; Riley JL; Peakman M; Maher J; Tree TI
    J Autoimmun; 2017 May; 79():63-73. PubMed ID: 28117148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific regulatory T cells: are police CARs the answer?
    Dawson NAJ; Levings MK
    Transl Res; 2017 Sep; 187():53-58. PubMed ID: 28688236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
    Koristka S; Kegler A; Bergmann R; Arndt C; Feldmann A; Albert S; Cartellieri M; Ehninger A; Ehninger G; Middeke JM; Bornhäuser M; Schmitz M; Pietzsch J; Akgün K; Ziemssen T; Steinbach J; Bachmann MP
    J Autoimmun; 2018 Jun; 90():116-131. PubMed ID: 29503042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building a CAR-Treg: Going from the basic to the luxury model.
    Rosado-Sánchez I; Levings MK
    Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric antigen receptor-engineered regulatory T lymphocytes: promise for immunotherapy of autoimmune disease.
    Yi L; Weifan Y; Huan Y
    Cytotherapy; 2019 Sep; 21(9):925-934. PubMed ID: 31105041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
    Selck C; Dominguez-Villar M
    Front Immunol; 2021; 12():661875. PubMed ID: 34054826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological functions of regulatory T cells.
    Shevach EM
    Adv Immunol; 2011; 112():137-76. PubMed ID: 22118408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision.
    Adair PR; Kim YC; Zhang AH; Yoon J; Scott DW
    Front Immunol; 2017; 8():1117. PubMed ID: 28983300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.